Automating the Future by Kim Nelson
Oct 13, 2017
The era of cell therapies are upon us – offering real potential for achieving remission or cures for cancer. To ensure that processes run smoothly, safely, and cost effectively, we must embrace a more automatic approach. There is just one problem – integrated off-the-shelf automated systems don’t yet exist.
CRB’s process engineer Kim Nelson, Senior Director, Strategic Consulting, was recently interviewed by Medicine Maker to find out his thoughts on the conundrum and the future of the field. Read the full article here to learn Kim’s insight into trends, challenges and opportunities for more promising treatments in the coming years.